Entheon Biomedical Corp. operates as a biotechnology research and development company. The firm engages in developing and commercializing dimethyltryptamine based psychedelic therapeutic products. Its therapies aim to treat addiction and substance use disorders. The company was founded on April 6, 2010 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Entheon Biomedical Corp market cap is $221,700.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Entheon Biomedical Corp 52 week high is $0.1038 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Entheon Biomedical Corp 52 week low is $0.0004 as of November 18, 2026.
Entheon Biomedical Corp stock price today is $0.016.
Entheon Biomedical Corp stock price yesterday was $0.0598.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Entheon Biomedical Corp's P/E ratio is 4.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Entheon Biomedical Corp P/B ratio is 0.6369.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Entheon Biomedical Corp 50-day moving average is $0.0186.